Your browser doesn't support javascript.
loading
Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials.
Qian, Li Jun; Gao, Yao; Zhang, Yan Mei; Chu, Ming; Yao, Jing; Xu, Di.
Afiliação
  • Qian LJ; Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Gao Y; Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Zhang YM; Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Chu M; Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Yao J; Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Xu D; Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. xudi1964@gmail.com.
Sci Rep ; 7(1): 238, 2017 03 22.
Article em En | MEDLINE | ID: mdl-28331223
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Inibidores de PCSK9 / Hiperlipoproteinemia Tipo II / Fatores Imunológicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Inibidores de PCSK9 / Hiperlipoproteinemia Tipo II / Fatores Imunológicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article